Hartman C - Search Results

1

Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1.

Basel-Vanagaite L, Zevit N, Har Zahav A, Guo L, Parathath S, Pasmanik-Chor M, McIntyre AD, Wang J, Albin-Kaplanski A, Hartman C, Marom D, Zeharia A, Badir A, Shoerman O, Simon AJ, Rechavi G, Shohat M, Hegele RA, Fisher EA, Shamir R. Basel-Vanagaite L, et al. Among authors: hartman c. Am J Hum Genet. 2012 Jan 13;90(1):49-60. doi: 10.1016/j.ajhg.2011.11.028. Epub 2012 Jan 5. Am J Hum Genet. 2012. PMID: 22226083 Free PMC article.

2

Intravenous lipid emulsions in term infants: impact on laboratory and clinical outcomes and long-term consequences.

Hartman C, Shamir R. Hartman C, et al. World Rev Nutr Diet. 2015;112:81-9. doi: 10.1159/000365493. Epub 2014 Nov 24. World Rev Nutr Diet. 2015. PMID: 25471805 Review.

3

Nutrition and growth: highlights from the first international meeting.

Hartman C, Shamir R. Hartman C, et al. Expert Rev Endocrinol Metab. 2012 Jul;7(4):407-410. doi: 10.1586/eem.12.31. Expert Rev Endocrinol Metab. 2012. PMID: 30754160

4

Follow-up of children with celiac disease - lost in translation?

Mozer-Glassberg Y, Zevit N, Rosenbach Y, Hartman C, Morgenstern S, Shamir R. Mozer-Glassberg Y, et al. Among authors: hartman c. Digestion. 2011;83(4):283-7. doi: 10.1159/000320714. Epub 2011 Feb 1. Digestion. 2011. PMID: 21282953

5

Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.

Hartman C, Eliakim R, Shamir R. Hartman C, et al. Isr Med Assoc J. 2004 Apr;6(4):221-6. Isr Med Assoc J. 2004. PMID: 15115261 Free article. Review. No abstract available.

6

Nutritional status and nutritional therapy in inflammatory bowel diseases.

Hartman C, Eliakim R, Shamir R. Hartman C, et al. World J Gastroenterol. 2009 Jun 7;15(21):2570-8. doi: 10.3748/wjg.15.2570. World J Gastroenterol. 2009. PMID: 19496185 Free PMC article. Review.

7

Food Intake Adequacy in Children and Adolescents With Inflammatory Bowel Disease.

Hartman C, Marderfeld L, Davidson K, Mozer-Glassberg Y, Poraz I, Silbermintz A, Zevit N, Shamir R. Hartman C, et al. J Pediatr Gastroenterol Nutr. 2016 Oct;63(4):437-44. doi: 10.1097/MPG.0000000000001170. J Pediatr Gastroenterol Nutr. 2016. PMID: 26925608

8

Long-term Extent Change of Pediatric-Onset Ulcerative Colitis.

Rinawi F, Assa A, Hartman C, Mozer Glassberg Y, Nachmias Friedler V, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Rinawi F, et al. Among authors: hartman c. J Clin Gastroenterol. 2018 Apr;52(4):326-332. doi: 10.1097/MCG.0000000000000741. J Clin Gastroenterol. 2018. PMID: 28067753

9

Long-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease.

Assa A, Hartman C, Weiss B, Broide E, Rosenbach Y, Zevit N, Bujanover Y, Shamir R. Assa A, et al. Among authors: hartman c. J Crohns Colitis. 2013 Jun;7(5):369-76. doi: 10.1016/j.crohns.2012.03.006. Epub 2012 Apr 5. J Crohns Colitis. 2013. PMID: 22483567

10

Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.

Rinawi F, Assa A, Hartman C, Mozer Glassberg Y, Friedler VN, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Rinawi F, et al. Among authors: hartman c. Inflamm Bowel Dis. 2016 Dec;22(12):2917-2923. doi: 10.1097/MIB.0000000000000937. Inflamm Bowel Dis. 2016. PMID: 27755214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

923 results

Search Page